VANGUARD GROUP INC - INDAPTUS THERAPEUTICS INC ownership

INDAPTUS THERAPEUTICS INC's ticker is and the CUSIP is 45339J105. A total of 18 filers reported holding INDAPTUS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of INDAPTUS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$690,811
+44.5%
250,748
+0.2%
0.00%
Q2 2023$478,165
+3.2%
250,3480.0%0.00%
Q1 2023$463,144
+27.6%
250,3480.0%0.00%
Q4 2022$363,005
-32.9%
250,348
+0.0%
0.00%
Q3 2022$541,000
-16.1%
250,247
+1.3%
0.00%
Q2 2022$645,000
-33.4%
246,947
+1.9%
0.00%
Q1 2022$969,000
-16.7%
242,235
+18.7%
0.00%
Q4 2021$1,163,000
+95.8%
204,019
+169.0%
0.00%
Q3 2021$594,00075,8410.00%
Other shareholders
INDAPTUS THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
STRATEGY ASSET MANAGERS LLC 45,336$86,5920.02%
INVESTMENT HOUSE LLC 108,282$206,8190.02%
Vivaldi Capital Management LP 24,000$45,8400.01%
Pine Valley Investments Ltd Liability Co 44,420$84,8430.01%
UBS Group AG 640$1,2220.00%
WELLS FARGO & COMPANY/MN 101$1930.00%
NORTHERN TRUST CORP 12,918$24,6730.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 7$130.00%
GEODE CAPITAL MANAGEMENT, LLC 50,521$92,4530.00%
View complete list of INDAPTUS THERAPEUTICS INC shareholders